Publications by authors named "Anna Eiring"

Claim this Profile
R
Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype.
Vutha Nhim, Alfonso E Bencomo-Alvarez, Luis Alvarado, Michelle Kilcoyne, Mayra A Gonzalez-Henry, Anna M Eiring

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facility type and cancer outcomes in the United States.
Michelle Kilcoyne, Vutha Nhim, Mayra A Gonzalez, Idaly M Olivas, Anna M Eiring

Ann Cancer Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer.
Boranai Tychhon, Jesse C Allen, Mayra A Gonzalez, Idaly M Olivas, Jonathan P Solecki, Anna M Eiring

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Anna M Eiring

Clin Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Idaly M Olivas, James E Young, Anna M Eiring

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.
Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M Eiring, Shrikanth S Gadad

Vaccines (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.
Helong Zhao, Anthony D Pomicter, Anna M Eiring, Anca Franzini, Jonathan Ahmann

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia.
Sara Ribeiro, Anna M Eiring, Jamshid S Khorashad

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi, Mohammad Kiani, Ali Allahgholipour, Anna M Eiring

Cells· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Andres J Rubio, Alfonso E Bencomo-Alvarez, James E Young, Vanessa V Velazquez, Joshua J Lara, Anna M Eiring

Cells· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.
Anthony D Pomicter, Phillip M Clair, Dongqing Yan, William L Heaton, Anna M Eiring

Acta Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordant PET Findings and a High Relapse Rate Characterize Hispanics With Hodgkin's Lymphoma Treated With ABVD.
Sumit Gaur, Alexander Philipovskiy, Umeanaeto Onyedika, Anna M Eiring, Alok K Dwivedi

Cancer Diagn Progn· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood cancer health disparities in the United States Hispanic population.
Alfonso E Bencomo-Alvarez, Andres J Rubio, Mayra A Gonzalez, Anna M Eiring

Cold Spring Harb Mol Case Stud· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
Alfonso E Bencomo-Alvarez, Mayra A Gonzalez, Andres J Rubio, Idaly M Olivas, Joshua J Lara, Anna M Eiring

Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, Mayra A Gonzalez, Rebecca Ellwood, Anna M Eiring

Oncogene· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
Ami B Patel, Anthony D Pomicter, Dongqing Yan, Anna M Eiring, Orlando Antelope

Leukemia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.
Hein Than, Anthony D Pomicter, Dongqing Yan, Larry P Beaver, Anna M Eiring

Leukemia· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy metabolism and drug response in myeloid leukaemic stem cells.
Alfonso E Bencomo-Alvarez, Andres J Rubio, Mayra A Gonzalez, Anna M Eiring

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
Dongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, Clinton C Mason, Anna V Senina, Anna M Eiring

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.
Jared A Wallace, Dominique A Kagele, Anna M Eiring, Carissa N Kim, Ruozhen Hu

Blood· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities.
Ahmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, Ping-Shan Lai, William L Heaton, Anna M Eiring

ChemMedChem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.
Anthony D Pomicter, Anna M Eiring, Anna V Senina, Matthew S Zabriskie, James E Marvin

Exp Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
Anna M Eiring, Brent D G Page, Ira L Kraft, Clinton C Mason, Nadeem A Vellore

Leukemia· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.
Jamshid S Khorashad, Anna M Eiring, Clinton C Mason, Kevin C Gantz, Amber D Bowler

Blood· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia.
Anna M Eiring, Michael W Deininger

Genome Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis